Atlantic Edge Private Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$334K Sell
923
-59
-6% -$20.2K 0.07% 117
2026
Q1
$346K Hold
982
0.08% 110
2025
Q4
$321K Hold
982
0.08% 110
2025
Q3
$277K Hold
982
0.07% 119
2025
Q2
$274K Hold
982
0.08% 116
2025
Q1
$306K Sell
982
-35
-3% -$10.3K 0.09% 108
2024
Q4
$265K Sell
1,017
-35
-3% -$10.4K 0.08% 118
2024
Q3
$339K Buy
1,052
+104
+11% +$34K 0.1% 107
2024
Q2
$296K Hold
948
0.1% 107
2024
Q1
$270K Sell
948
-24
-2% -$7.02K 0.09% 111
2023
Q4
$280K Buy
+972
New +$265K 0.11% 106

Other funds holding AMGN

Atlantic Edge Private Wealth Management's AMGN Position: Q2 2026 in Review

Atlantic Edge Private Wealth Management reduced its Amgen (AMGN) stake by 6% in Q2 2026, selling an estimated $20.2K and leaving 923 shares worth $334K. The position accounts for 0.07% of the portfolio, ranked #117.

Atlantic Edge Private Wealth Management first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $346K in Q1 2026. 1,285 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Atlantic Edge Private Wealth Management held 923 shares of Amgen worth $334K as of Q2 2026.
  • Atlantic Edge Private Wealth Management sold 59 Amgen shares in Q2 2026, an estimated $20.2K.
  • Amgen made up 0.07% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #117 holding.
  • Atlantic Edge Private Wealth Management first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Atlantic Edge Private Wealth Management's Amgen position peaked at $346K in Q1 2026.
  • 1,285 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.